Sequence-dependent enhancement of paclitaxel toxicity in non–small cell lung cancer by 17-allylamino 17-demethoxygeldanamycin
Open Access
- 1 November 1999
- journal article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 118 (5), 908-915
- https://doi.org/10.1016/s0022-5223(99)70061-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Dual effect of erbB-2 depletion on the regulation of DNA repair and cell cycle mechanisms in non-small cell lung cancer cellsOncogene, 1998
- Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1AOncogene, 1997
- Polyubiquitination and Proteasomal Degradation of the p185c-B-2 Receptor Protein-tyrosine Kinase Induced by GeldanamycinJournal of Biological Chemistry, 1996
- p185erbB2 Binds to GRP94 in VivoPublished by Elsevier BV ,1996
- Enhanced Chemoresistance by Elevation of p185neu Levels in HER-2/neu-Transfected Human Lung Cancer CellsJNCI Journal of the National Cancer Institute, 1995
- Preclinical pharmacologic evaluation of geldanamycin as an antitumor agentCancer Chemotherapy and Pharmacology, 1995
- Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycleInternational Journal of Cancer, 1994
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986
- Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.The Journal of cell biology, 1975